Graham

(IN BRIEF) Researchers at The Institute of Cancer Research and Queen Mary University have created EIRAs, a computational assay that predicts how bowel cancer cells evolve resistance to chemotherapy. By monitoring cell populations and applying evolutionary models, the tool differentiates … Read the full press release →

(IN BRIEF) The EIB and Greece’s CDLF have signed a €500 million loan under the Antonis Tritsis urban investment programme, bringing the EIB’s total commitment to €1 billion. The funds will support hundreds of local authority projects—ranging from water and … Read the full press release →

(IN BRIEF) The University of Southampton’s new E-beam lithography facility, which is the second of its kind globally, will significantly advance semiconductor technology in the UK. The facility, which provides unmatched accuracy in designing the components of future technologies, supports … Read the full press release →

(IN BRIEF) The European Investment Bank is teaming up with Growthfund to carry out Climate Risk and Vulnerability Assessments for the ports of Volos, Alexandroupoli, and Patras in Greece. The initiative will identify physical climate risks, propose adaptation measures, and … Read the full press release →

(IN BRIEF) Researchers at the University of Glasgow have demonstrated that users in passive virtual reality environments can experience radically altered perceptions of motion—including exaggerated or reversed movement—without experiencing discomfort or motion sickness. The study, to be presented at CHI … Read the full press release →

(IN BRIEF) In 2024, the European Investment Bank (EIB) Group provided €2.2 billion in financing to Greece, focusing on boosting energy resilience, supporting business growth, and enhancing disaster preparedness. Key projects included solar parks, grid upgrades, and disaster management infrastructure, … Read the full press release →

(IN BRIEF) The European Investment Bank (EIB) will provide advisory support to five Greek regions to facilitate their transition from lignite-based energy production to sustainable, renewable energy sources. Through a €2.75 million technical assistance fund, the EIB aims to promote … Read the full press release →

(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP). Scemblix achieved significantly higher major … Read the full press release →

(IN BRIEF) Novartis has secured European Commission approval for Kisqali® (ribociclib) in combination with endocrine therapy (ET) as an adjuvant treatment for high-risk hormone receptor-positive (HR+), HER2-negative early breast cancer (EBC). The approval, based on the Phase III NATALEE trial, … Read the full press release →

(IN BRIEF) The European Investment Bank (EIB) Group has opened a new office in Nicosia, Cyprus, signaling its strengthened commitment to supporting the country’s sustainable development goals. During the inauguration, EIB President Nadia Calviño and Cypriot leaders discussed investment priorities, … Read the full press release →